Merit Medical Systems, Inc. with ticker code (MMSI) have now 8 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The target price High/Low ranges between 98 and 78 calculating the average target price we see $87.88. Now with the previous closing price of $84.44 this is indicating there is a potential upside of 4.1%. Also worth taking note is the 50 day moving average now sits at $77.71 and the 200 day MA is $68.75. The market capitalization for the company is 4.64B. The stock price for Iron Mountain Incorporated is 80.66 USD
The potential market cap would be $4,826,358,210 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 57.61, revenue per share of 20.58 and a 4.13% return on assets.
Merit Medical Systems, Inc. is a manufacturer and marketer of medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. It offers products in five product categories: peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer (OEM) and endoscopy.
